My bad, jjson. In the post in which you provided the information, Ocugen and Biogen were both being discussed, and I misremembered that Woodcock asked the IG to look into Biogen, not Ocugen.
"Woodcock Seeks Outside Investigation to Restore FDA Credibility July 12, 2021 Jill Wechsler, Pharm Exec’s Washington Correspondent"
Market Data 
Markets 
AI
